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Lipid Uptake by Alveolar 
Macrophages Drives Fibrotic 
Responses to Silica Dust
Xiaomin Hou1, Ross Summer2, Ziying Chen1, Ying Tian1, Jingjing Ma1, Jie Cui1, Xiaohui Hao3, 
Lingli Guo3, Hong Xu2,3, Hongli Wang1 & Heliang Liu1,3
Silicosis is a common occupational disease and represents a significant contributor to respiratory 
morbidity and mortality worldwide. Lipid-laden macrophages, or foam cells, are observed in the lungs 
of patients with silicosis but the mechanisms mediating their formation remain poorly understood. In 
this study, we sought to elucidate the mechanisms by which silica promotes foam cell formation in the 
lung, and to determine whether uptake of lipids alone is sufficient to drive TGF-β production by alveolar 
macrophages. Consistent with previous reports, we found that foam cells were markedly increased 
in the lungs of patients with silicosis and that these findings associated with both higher levels of 
intracellular lipid levels (oxidized LDL, ox-LDL) and elevated transcript levels for the lipid scavenger 
receptor CD36 and the nuclear receptor PPARγ. Employing a rat alveolar macrophage cell line, we found 
that exposure to silica dust or ox-LDL alone had a modest effect on the induction of foam cell formation 
and only silica was capable of inducing the production of TGF-β. In contrast, foam cell formation and 
TGF-β production were both dramatically increased when cells were exposed to a combination of 
silica dust and ox-LDL. Moreover, we found that these endpoints were markedly attenuated by either 
blocking CD36 or inhibiting the activity of PPARγ. Altogether, our findings suggest that foam cell 
formation and TGF-β production are driven by the simultaneous uptake of silica and lipids in alveolar 
macrophages and that strategies aimed at blocking lipid uptake by alveolar macrophages might be 
effective in ameliorating fibrotic responses to silica in the lung.
Silicosis is an occupational lung disease caused by exposure to crystalline silica dust (SiO2), which is a major 
constituent of soil, sand and most other types of rock. While silicosis is now a relatively uncommon respiratory 
condition in many regions of the world that have strict occupational safety standards, it remains a frequent cause 
of respiratory morbidity and mortality in many other regions of the world, including China. For example, in 2013 
approximately 25,000 new cases of silicosis were diagnosed in China alone, which is a number that nearly equals 
the incidence of idiopathic pulmonary fibrosis (IPF) in the United States. However, unlike IPF, treatments for 
silicosis do not exist, illustrating the importance of gaining additional mechanistic insight into this condition.
Alveolar macrophages (AM) are the first line of defense against foreign substances entering the lower airways, 
and are essential for clearing silica dust from the lung1. Moreover, uptake of silica dust by AMs has been shown 
to play an important role in the pathobiology of silicosis, not only by driving the production of factors that con-
tribute to lung inflammation but also by promoting the production of pro-fibrotic substances. For reasons that 
remain unclear, exposure to silica dust in both rodents and humans has been shown to induce the formation of 
foam cells, which are AMs that have accumulated increased amounts of intracellular lipids2–4. Although the role 
of foam cells in the pathobiology of silicosis remains unknown, recent reports have indicated that lipid uptake by 
AMs can by itself polarize cells to an M2 pro-reparative phenotype in the setting of bleomycin exposure, suggest-
ing that foam cells may actually contribute to fibrotic remodeling in the silica-exposed lung.
To date, our understanding of the mechanisms contributing to foam cell formation are largely driven by work 
in the cardiovascular field5–7. In this context, it has been shown that the uptake of ox-LDL contributes signif-
icantly to the formation of foam cells and also triggers many of the events that underlie the development and 
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progression of atherosclerosis8,9. Moreover, the uptake of ox-LDL has been shown to be mediated by several scav-
enger receptors on the surface of macrophages, most notably CD36, which is an 88-kDa glycoprotein responsible 
for an estimated 75% ox-LDL uptake1,10. Once taken up by macrophages, cholesterol and other lipids have been 
shown to activate fatty acid binding proteins and other intracellular lipid receptors, such as the liver x receptor 
(LXR) and PPARγ11–14. In turn, this activation drives transcriptional events that lead to the upregulation of var-
ious transporter proteins that then serve to facilitate the efflux of lipids from cells. Although the mechanisms 
mediating macrophage lipid clearance in the lung are less well-understood it has been shown that AMs express 
most, if not all, of the machinery involved in the uptake and clearance of lipids in atherosclerotic plaques. With 
this in mind, our primary objectives in this study were to determine whether silicosis alters the expression of the 
machinery involved in regulating lipid homeostasis in AMs, and to determine whether exposure to SiO2 or lipids 
alone can drive AMs to adopt a foam cell appearance and produce TGF-β.
Results
SiO2 induces foam cell formation in alveolar macrophage of the human lung. The baseline char-
acteristics of subjects in our study are shown in Table 1. We did not detect significant difference in age, smoking 
status or alcohol consumption between our groups (P < 0.05). As shown in Fig. 1, we found that AMs collected 
from patients with silicosis were on average larger, and exhibited a foamy appearance, as evidenced by the intense 
staining for neutral lipids (Oil Red O) in cells that were cytospun onto glass slides. Further, we found that the 
percentage of foam cells increased with the severity of disease and this was most apparent when cell morphology 
between individuals with stage III disease (P < 0.05) (Fig. 1A,B). Consistent with these findings, electron micros-
copy showed large number of low density vacuoles in the cytoplasm of AMs from patients with stage III disease, 
a findinglipids (Fig. 1D).
To delineate the type of lipids that accumulated we measured levels of cholesterol, triglycerides and ox-LDL 
in BAL fluid and AMs. As shown in Fig. 2, we found that cholesterol levels were increased in BALF and AMs 
silicosis, and that levels were associated with more severe disease. Indeed, cholesterol levels in stage III disease 
were markedly increased when compared to levels in all other stages (P < 0.05). Interestingly, triglyceride levels 
were not significantly increased in the BALF of patients with silicosis (P < 0.05), and levels in AMs showed only a 
modest elevation (P < 0.05). Like cholesterol, levels of ox-LDL were dramatically increased in cells collected from 
BAL fluid of silicosis patients (Fig. 2E), and levels were also increased at each stage of disease (P < 0.05). However, 
ox-LDL levels in the BAL fluid showed an inverse correlation with the severity of disease in contrast to cholesterol 
levels (P < 0.05). As shown in Fig. 2, we found a positive correlation (r = 0.343) between ox-LDL in AMs and 
cholesterol concentration in BALF (P < 0.05) (Fig. 2G) and a negative correlation (r = −0.335) between ox-LDL 
levels in the BALF and cholesterol levels in AMs (P < 0.05) (Fig. 2H). Consistent with cells that had accumulated 
intracellular lipids, we also found that transcript levels for the lipid scavenger receptor CD36 and the intracellular 
lipid receptor PPAR-γ were significantly increased in BAL cells from silicosis patients (Fig. 3A,B) (P < 0.05), sup-
porting the notion that lipid homeostasis is altered in pulmonary silicosis.
SiO2 augments foam cell formation in ox-LDL exposed NR8383 macrophages. To further study 
the effects of SiO2 on the formation of foam cells we employed an in vitro model system using NR8383 cells, a rat 
cell line often used to model human AMs in culture. Using these cells, we examined the impact of SiO2, ox-LDL 
and combined exposures on the formation of foam cells. As shown in Fig. 4, we found that exposing cells to either 
low (50 μg/ml) or high (100 μg/ml) concentrations of SiO2 had only a modest effect on the formation of foam 
cells. Similarly, we found that exposing cells to lipids alone (ox-LDL) only modestly induced foam cell formation 
in NR8383 cells. In contrast, when cells were exposed to combined treatments of SiO2 and ox-LDL we detected 
a dramatic increase in the number and size of foam cells and this associated with a marked increase in levels of 
total cholesterol, free cholesterol and cholesterol esters in cells (Fig. 4C,D), suggesting that SiO2 augments the 
formation of foam cells in the confines of a lipid rich environment like the lung.
SiO2 augments PPARγ and CD36 expression in ox-LDL exposed NR8383 cells. To investigate 
whether SiO2 can also alter expression of the machinery involved in regulating AM lipid levels we next examined 
transcript and protein levels for CD36 and PPARγ in NR8383 cells. Although SiO2 treatment alone did not signif-
icantly alter the expression of these genes, we found that transcript and protein levels of CD36 and PPARγ were 
both significantly increased in cells exposed to SiO2 plus ox-LDL (Fig. 5A–D). Together, these findings provide 
further support for the concept that SiO2 disrupts lipid homeostasis in AMs.
Clinical characteristics
Control 
(N = 8)
Silicosis I 
(N = 18)
Silicosis II 
(N = 17)
Silicosis III 
(N = 24)
Age 47.25 ± 5.8 46.33 ± 5.61 45.88 ± 5.44 48.92 ± 6.68
BMI 21.99 ± 3.45 23.51 ± 2.69 21.34 ± 2.55 22.86 ± 3.36
Dusting years 19.39 ± 10.47 12.18 ± 6.31 14.42 ± 7.25
Dust removal period 3.61 ± 6.03 6.0 ± 5.6 4.58 ± 5.51
Smokers/no smokers 6/2 17/1 14/3 16/8
Drinkers/no drinkers 5/3 13/5 15/2 15/9
Table 1. Clinical characteristics of study subjects. Values are mean ± SD. P-values were calculated by one-way 
ANOVA tests (for age and BMI) or chi-square test (for smoker, drinker, out of the dust environment).
www.nature.com/scientificreports/
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SSO inhibits SiO2–induced foam cell formation in ox-LDL exposed NR8383 cell. To assess 
whether CD36 is required for the formation of foam cells in our in vitro model, we next treated NR8383 cells 
with a pharmacological inhibitor of CD36 called SSO. As shown in Fig. 6, we found that treatment with SSO 
effectively inhibited the upregulation of transcript and protein levels of CD36 (Fig. 6A–D) in the setting of SiO2 
plus ox-LDL exposure. Further, we found that the downregulation of CD36 by SSO also associated with a marked 
reduction in intracellular lipid accumulation, as evidenced by the dramatic decrease in total cholesterol levels, 
CE/TC ratios (75.66% vs 21.42%) (Fig. 6H), and the number lipid droplets in SiO2 plus ox-LDL exposed NR8383 
cells (P < 0.05) (Fig. 6E,F). Together, these findings suggest that blocking CD36 might be effective in inhibiting 
foam cell formation in the silica exposed lung.
Blocking PPARγ activity reduces SiO2-induced foam cell formation. Next, to explore whether the 
PPARγ pathway is involved in regulating foam cell formation in AMs we pre-treated NR8383 cells with GW9662 
for 2 h, which is a high-affinity PPARγ inhibitor known to abrogate PPARγ activation in various model systems15. 
As shown in Fig. 7, we found that treatment with GW9662 significantly reduced transcript and protein levels for 
PPARγ in NR8383 cells exposed to SiO2 plus ox-LDL (Fig. 7A–C). Interestingly, these findings also associated 
with a marked decrease in transcript and protein levels for CD36 (Fig. 7D). More importantly, we found that 
GW9662 dramatically reduced the quantity of intracellular lipids, as measured by the intensity of Oil Red O 
staining (Fig. 7E,F), levels of total cholesterol, free cholesterol and cholesterol esters in whole cell lysates and 
the ratio of cholesterol esters to total cholesterol in cultured cells (Fig. 7G,H). Together, these results show that 
the blocking PPARγ activity can be effective in inhibiting foam cell formation, perhaps by downregulating the 
expression of CD36 on AMs.
Figure 1. Alveolar macrophages (AM) from patients with and without silicosis are observed under the 
microscope. (A,C) AMs of (a) controls, (b) silicosis of stage I, (c) silicosis of stage II, (d) silicosis of stage III were 
viewed under inverted-microscope at magnification (400×) after Oil red O staining (black arrow) for neutral 
lipids or HE staining. (B) Percent positive foam cells were quantified. (D) AMs of (a) controls, (b) silicosis of 
stage I, (c) silicosis of stage II, (d) silicosis of stage III were observed by transmission electron microscopy from 
patients with and without silicosis. Red arrows highlight vacuolated areas consistent with lipid droplets.
www.nature.com/scientificreports/
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Foam cell formation induces the production of TGF-β secretion. Finally, to determine whether the 
formation of foam cells might actually contribute to fibrotic remodeling in the lung we compared levels of TGF-β 
in control and lipid-filled NR8383 cells. As shown in Fig. 8, we found that levels of TGF-β were significantly 
increased in BALF of patients with silicosis when compared to controls (P < 0.05). Similarly, we found that TGF-β 
production was also increased when NR8383 cells were exposed to combined treatments of SiO2 and ox-LDL but 
levels of TGF-β only increased marginally in cells exposed to ox-LDL alone. Importantly, we found that treatment 
of cells with either GW9662 or SSO to block PPARγ and CD36, respectively, effectively reduced the expression 
of TGF-β in SiO2 and ox-LDL exposed cells (P < 0.05), suggesting that pro-fibrotic responses by foam cells in the 
lungs of silicosis patients can be attenuated by these therapies (Fig. 9).
Figure 2. Lipid levels in bronchoalveolar lavage fluid and alveolar macrophages of subjects with and without 
silicosis. (A–F) Cholesterol, triglyceride and ox-LDL in BALF and AM in control subjects and patients with 
silicosis. (G,H) Dot plots showing correlation between ox-LDL levels and cholesterol levels in patients with 
silicosis. Data are presented as the mean ± SD from a duplicate of each sample and from three independent 
experiments (n = 3); #p < 0.05; ##p < 0.01; ###p < 0.001 versus the control group, &p < 0.05; &&p < 0.01; 
&&&p < 0.001 versus the silicosis I group, *p < 0.05; **p < 0.01; ***p < 0.001 versus silicosis III group.
www.nature.com/scientificreports/
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Discussion
Foam cells are a hallmark feature of diseased tissues in a wide range of organs, including the lung, particularly in 
the setting of pulmonary fibrosis. In this study, we sought to elucidate the mechanisms by which foam cells form 
in the silica-exposed lung and to determine whether these cells might have a contributory role in the formation 
of pulmonary scar tissue. Interestingly, we found that SiO2 alone had only a marginal effect on the formation of 
foam cells but readily promoted their formation when placed in the context of a lipid-rich environment. Further, 
Figure 3. PPARγ and CD36 transcript levels in human AMs from individuals with and without silicosis. 
Values were mean ± SD of three independent experiments (n = 3). ##: p < 0.01; ###p < 0.001 versus the control 
group; &p < 0.05; &&p < 0.01; &&&p < 0.001 versus the silicosis I group; *p < 0.05; **p < 0.01; ***p < 0.001 versus 
silicosis III group.
Figure 4. Combined exposure to SiO2 and ox-LDL induces NR8383 foam cell formation. (A) Foam cells readily 
formed in cells exposed to SiO2 plus ox-LDL (d) compared with control group (a), SiO2 group (b) and ox-LDL 
group (c) as evidenced by Oil Red O staining (400x). (B) Percent positive foam cells were quantified. (C) Total 
cholesterol (TC), free cholesterol (FC) and cholesterol ester (CE) levels in NR8383 cells in response to different 
conditions. (C) CE to TC ratios in NR8383 cells exposed to different conditions. Data are presented as the 
mean ± SD (n = 3). #p < 0.05; ###p < 0.001 versus the control group; *p < 0.05; **p < 0.01; ***p < 0.001 versus 
the SiO2 + ox-LDL group.
www.nature.com/scientificreports/
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we found that combined exposures of SiO2 and ox-LDL not only markedly enhanced foam cell formation but also 
dramatically upregulated the production of TGF-β. Moreover, we showed that by blocking either the uptake of 
lipids or the activation of downstream signaling events in AMs we could effectively decrease TGF-β production 
Figure 5. Combined treatment with SiO2 and ox-LDL induced CD36 and PPARγ expression in alveolar 
macrophages. (A) Western blot for CD36 and PPARγ in NR8383 cells exposed to different conditions. GAPDH 
was used as loading control. (B) Transcript levels for CD36 and PPARγ in NR8383 cells exposed to different 
conditions. (C,D) Immunofluorescence staining for CD36 and PPARγ in NR8383 cells exposed to different 
conditions. DAPI was used to stain nuclei (blue). All images show × 60 original magnifications. Data represent 
the mean ± SD from three independent experiments(n = 3). *p < 0.05; **p < 0.01; ***p < 0.001 versus the 
SiO2 + ox-LDL group. &p < 0.05; &&p < 0.01; &&&p < 0.001 versus the ox-LDL group.
www.nature.com/scientificreports/
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Figure 6. Inhibition of CD36 blocks foam cell formation in NR8383 cells. (A,B) NR8383 cells (1 × 106/ml) 
were pretreated with CD36 inhibitor, SSO (10 μM) for 2 h and then treated with SiO2 + ox-LDL (50 μg/ml) 
isolated from different individuals for 36 h. Expression of CD36 and PPARγ transcript and protein levels were 
analyzed. (C,D) Immunofluorescent staining for CD36 and PPARγ (ret) and nuclei (blue) in NR8383 cells 
exposed to different conditions. (E) Oil Red O staining of NR8383 cells exposed to different conditions (400x). 
(F) Percent positive foam cells were quantified. (G, H) Intracellular total cholesterol (TC), free cholesterol (FC) 
and cholesterol ester (CE) levels or the ratio of CE to TC was determined in NR8383 cells exposed to different 
conditions. All data are expressed as mean ± SD from at least three independent experiments in triplicate. 
#p < 0.05; ###p < 0.001 versus the DMSO group; &&&p < 0.001 versus the SiO2 + ox-LDL + SSO group; *p < 0.05; 
**p < 0.01; ***p < 0.001 versus the SiO2 + ox-LDL + DMSO group.
www.nature.com/scientificreports/
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in cultured cells16–18. Together, our findings suggest that targeting foam cell formation might be a novel strategy 
for treating silicosis and, perhaps, other fibrotic lung diseases as well.
While other groups have shown that foam cells accumulate in the lungs of patients with silicosis our work 
is the first to demonstrate that this is also associated with a dramatic increase in levels of ox-LDL within AMs. 
Further, our data indicate that uptake of ox-LDL synergizes with silica dust to drive fibrotic responses in AM. Of 
note, ox-LDL is a lipid found abundantly throughout the body but accumulates more in diseased tissues. When 
compared to non-oxidized LDL, ox-LDL tends to promote cellular dysfunction by activating inflammatory path-
ways, explaining why its accumulation has been linked to various diseases, including coronary artery disease and 
Figure 7. PPARγ inhibitors reduce foam cell formation in NR8383 cells. (A–C) Protein and transcript levels for 
CD36 and PPARγ in NR8383 cells exposed to different conditions. (D) Immunofluorescence images of CD36 
and PPARγ (red) in NR8383 cells exposed to different conditions. DAPI was used to stain nuclei (blue, 600x). 
(E) Oil Red O staining in NR8383 cells exposed to different conditions (400x). (F) Percent positive foam cells 
were quantified. (G,H) Intracellular cholesterol levels and the ratio of CE to TC were determined in NR8383 
cells exposed to different conditions. Data are expressed as mean ± SD from three independent experiments. 
###p < 0.001 versus the control group; *p < 0.05; **p < 0.01; ***p < 0.001 versus the SiO2 + ox-LDL + DMSO 
group.
www.nature.com/scientificreports/
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peripheral artery disease19,20. In these contexts, the uptake of ox-LDL drive cellular responses that not only lead 
to endothelial dysfunction but also to the progression of atherosclerosis21–23. Relevant to pulmonary fibrosis, it is 
also appreciated that a characteristic feature of foam cell-rich atherosclerotic plaques is a thick fibrous caps on the 
exterior surface24, suggesting that uptake of ox-LDL might also contribute to fibrotic remodeling in this disease.
Another important finding in our study was the observation that levels of CD36 are dramatically increased in 
AMs in response to SiO2 and ox-LDL exposure. CD36 belongs to the B family scavenger receptor25, a transmem-
brane protein receptor26 expressed on the surface of a variety of cells such as monocytes, macrophages, smooth 
muscle cells, and others. Because CD36 is a well-known lipid receptor, our findings suggest that the upregulation 
of CD36 on AMs may be an attempt to reduce extracellular lipid concentrations in the lung. Although this adap-
tive response may make sense in the setting of high levels of extracellular lipids, our findings also suggest that this 
response may contribute to fibrotic remodeling by augmenting TGF-β production in SiO2 and lipid exposed AMs. 
Notably, we are not the first group to demonstrate that levels of CD36 expression influence fibrotic responses. 
For example, Parks et al. showed that mice lacking CD36 were protected from developing pulmonary fibrosis to 
Figure 8. Foam cell formation induces the production of TGF-β. (A). TGF-β levels in BALF of patients with 
silicosis. (B) TGF-β levels in AMs of patients with silicosis. (C–E) The expression of TGF-βin NR8383 cell 
culture supernatants in different treatment groups. Data are expressed as mean ± SD from three independent 
experiments. #p < 0.05; ##p < 0.01; ###p < 0.001 versus the control group; *p < 0.05; **p < 0.01; ***p < 0.001 
versus the SiO2 + ox-LDL + DMSO group; &p < 0.05; &&p < 0.01; &&&p < 0.001 versus the silicosis I group.
www.nature.com/scientificreports/
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bleomycin27. Taken together, these findings suggest that pharmacological methods aimed at reducing lipid inflow 
to AMs may be effective in preventing or treating silicosis.
In addition to CD36, we found that PPARγ levels were also increased in AM exposed to SiO2 and ox-LDL28–30 
and in human primary AMs in the late stages of silcosis. Why levels of PPARγ were increased only in the late 
stages of human disease is unclear but we speculate this can be explained by several factors. First, foam cells rep-
resent only a small minority of the total cell population of lung macrophages in patients with early stage silicosis 
(Fig. 1), making their overall contribution to PPARγ expression relatively small. Moreover, while all cells are 
exposed to silica in culture this is not the case when silica is inhaled into the airways of the lung. Finally, it is also 
possible that injured AMs are rapidly replaced by circulating monocytes in early stages of disease but trafficking 
in and out of the lung is compromised in later stages of pulmonary fibrosis, thereby leading to an accumulation of 
injured and foamy appearing cells in the lung.
While our study suggests that SiO2 promotes lipid uptake in the lipid-rich environment of the lung it is also 
important to note that intracellular lipid concentrations are also dependent on the efflux of lipids from the cyto-
plasm. This activity is dependent on one or more of the known ATP-dependent transporter proteins on the 
plasma membrane of AMs such as ABCG1 or ABCA131–34. Because our study did not evaluate the impact of silica 
on the efflux of lipids, these types of studies will be important for future investigations.
Another notable finding in our study was the observation that TGF-β levels were only modestly increased in 
AMs when exposed to ox-LDL alone but levels markedly increased when cells were exposed to combined treatments 
of SiO2 plus ox-LDL. These findings indicate that SiO2 somehow synergizes with ox-LDL to drive fibrotic responses. 
Importantly, we showed that blocking lipid uptake/signaling by either inhibiting CD36 or PPARγ was highly effec-
tive in reducing TGF-β to these combined exposures, suggesting targeting these molecules might be effective in 
the treatment of silicosis. That said, we recognize the best way to reduce the burden of silicosis would be to prevent 
disease by limiting exposure to silica dust. However, effective preventive strategies have yet to be employed in many 
regions of the world, making it important to consider novel treatment approaches for these individuals.
We would like to point out that our study has several notable limitations. First, we recognize that our study 
was performed only on individuals from China, making it difficult to interpret whether our findings our appli-
cable to more diverse populations. Also, our in vitro studies were performed using a rat macrophage cell line 
rather than primary cells. Thus, at some point, our findings will ultimately need to be confirmed using primary 
macrophages from the human lung.
In conclusion, our work describes a novel mechanism by which SiO2 might conspire with lipids to drive foam 
cell formation and trigger the production of pro-fibrotic substances and that targeting foam cells might be a new 
avenue for the prevention or treatment of silicosis. We believe these findings have broad implications for the field of 
pulmonary medicine and other fields in which the formation of foam cells is a characteristic pathological feature.
Methods
Study subjects. Study subjects were seen in the Beidaihe Chinese coal workers nursing home. All patients 
were referred to our hospital for a one-time whole lung lavage. Silicosis was diagnosed based on GBZ-70–2009 
“Diagnostic criteria of pneumoconiosis”. Patients were excluded from the study for any of the following: (1) active 
pulmonary tuberculosis; (2) known heart disease; (3) bacterial pneumonia; (4) liver cirrhosis or hyperlipidemia. 
By nature of fact that silicosis is mostly a disease of men, all subjects in our study were males. The control group 
of 8 cases included 5 normal subjects and 3 cases of aspiration pneumonitis. Due to the challenges of recruiting 
Figure 9. SiO2 promotes the uptake of ox-LDL from alveolar macrophages, perhaps augmenting CD36-PPARγ 
signaling.
www.nature.com/scientificreports/
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normal subjects for lung lavage we were only able to obtain samples from 8 controls. This study was approved by 
the Clinical Trial and Ethics Committee of North China University of Science and Technology, and all partici-
pants provided written informed consent.
Chemicals and reagents. Ham’s F12K, Roswell Park Memorial Institute-1640 (RPMI-1640), fetal bovine 
serum (FBS) and penicillin-streptomycin were purchased from Invitrogen (Gibco, USA). SiO2 (particle size: 0.5 
∼ 10.0 μm, 80% of particle size is 1.0 ∼ 5.0 μm), GW9662, Dimethyl sulfoxide (DMSO), and Oil red O were 
from Sigma. Ox-LDL was purchased from Yiyuan Biotechnologies (Guangzhou, China). SSO was from Toronto. 
Primary antibody of CD36 (1:8000 dilution), PPARγ (1:800 dilution), GAPDH (1:2500 dilution) and conjugated 
with horseradish peroxidase (1:1000 dilution) were purchased from Abcam (Abcam, Cambridge, MA, USA). Cell 
Viability Assay Kit MTS was from Promage in the United States. Cholesterol, triglyceride and ox-LDL ELISA kits 
are available at Biovision in the United States. TGF-β were purchased from ABclone (USA). Total Cholesterol and 
Free Cholesterol Kit were obtained at Beijing Puli Lai Gene Technology Co, Ltd. Reverse transcription kit and 
SYBR Green qPCR reaction kits were from Takara, Japan.
Whole lung lavage and isolation of bronchoalveolar lavage fluid (BALF) and AM. Whole lung 
lavage was performed per published protocols. In China, whole lung lavage is used to treat silicosis. In brief, 
subjects are placed under general anesthesia and intubated with a large-capacity double-lumen tube. Unilateral 
lung lavage is then performed using 10000 ml–12000 ml in 500 ml aliquots. Recovered fluid is sterile- filtered and 
aliquots are removed for conventional cell counting and staining as well as isolation of cell pellets and BAL fluid 
for later analysis.
Cell culture. The NR8383 rat alveolar macrophage cell line was purchased from Chinese Academy of Sciences 
Shanghai Cell Bank. The cell density was adjusted to 2 × 105 cells /ml with F12K medium (adding 1% penicillin 
and streptomycin) with volume fraction of 15.0% fetal bovine serum, and cultured in incubator. The medium was 
changed every 2 to 3 days.
Histology. Hemotoxylin and eosin staining and Oil red O staining were performed as previously described.
Electron microscopy. Human alveolar macrophage pellets were fixed using standard protocols and as pre-
viously described.
Enzyme-Linked Immunosorbent Assay (ELISA). Cholesterol, triglyceride, ox-LDL and TGF-β levels 
were measured in AMs and BALF using commercially available ELISA kits. Experimental steps were performed 
according to manufacturer’s protocol.
Measurement of total cholesterol, free cholesterol and cholesterol ester in NR8383. The total 
cholesterol (TC), free cholesterol (FC) levels were determined according to the Kit instructions at 450 nm by a 
microplate reader, and the proportion of intracellular cholesterol ester (CE) was calculated. [CE% = (TC − FC)/TC].
Western blot analysis. Total protein concentration was determined by a BCA assay kit. The samples (30 μg) 
were then heated denatured and separated on 10% SDS-PAGE before being transferred to a PVDF membrane. 
Membrane was blocked with 3.5% skim milk containing 0.05% Tween-20 (TBST) for 3 hour, followed by incuba-
tion with primary antibodies at 4 °C overnight. The incubation time for secondary antibody was 2 hour at room 
temperature. An enhanced Chemiluminescence detection system was used for detection.
Real-time quantitative real-time PCR. Total cellular RNA was isolated from treated cells using Trizol. 
RNA concentration and purity were determined by absorbance measurements at 260 nm and 280 nm (A260/
A280 = 1.8–2.1) using a NanoDrop 8000 Spectrophotometer. cDNA was synthesized using the PrimeScriptTM RT 
reagent Kit. The transcribed cDNA was amplified with 200 ng cDNA using SYBR Green detection chemistry on 
the ABI 7500 Sequence Detection System. Relative expression levels were determined using the 2−ΔΔCt method. 
The sequences of PCR primers used in this study are as follow (Table 2).
Immunofluorescence for PPARγ and CD36 expression. Cells were fixed with 4% (w/v) paraform-
aldehyde for 15 min at room temperature, blocked with BSA, followed by blocking with normal goat serum for 
60 min, and then incubated with antibody (1:100) overnight at 4 °C. After incubation with a secondary TRITC 
conjugated antibody and DAPI, the cells were washed with PBS, mounted in anti-fade reagent and then observed 
using laser scanning confocal microscope.
Gene Sequences of primers Amplicon
PPARγ
Forward 5′-CACGGTTGATTTCTCCAGCATTTC-3′
135
Reverse 5′- GCAGGCTCTACTTTGATCGCACT-3′
CD36
Forward 5′-TTCTCATGCCGGTTGGAGACCTA-3′
172
Reverse 5′- TTGCTGCTATTCTTTGCCACTTC-3′
GAPDH
Forward 5′-CCATCACGCCACAGTTTCC-3′
357
Reverse 5′-ATCAGCAATGCCTCCTGCA-3′
Table 2. Sequences of primers and size of products for PCR.
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Statistical analysis. Statistical analysis was performed using SPSS statistical software, version 22.0. All 
the experiments were repeated at least three times. Data were expressed as means ± standard deviations (SD). 
Inter-group differences were analyzed using one-way ANOVA for the comparison of three or more groups. The 
value of p < 0.05 was considered statistically significant.
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